Oramed Pharmaceuticals (ORMP) Shares Issued (2016 - 2025)
Oramed Pharmaceuticals (ORMP) posted Shares Issued of $283008.0 for Q4 2025, down 80.38% on a QoQ basis from $1.4 million in Q4 2024, and down 80.38% year-over-year from $1.4 million in Q4 2024.
Oramed Pharmaceuticals (ORMP) Shares Issued (2016 - 2025) Analysis & Trends
Oramed Pharmaceuticals' Shares Issued history runs 10 years deep, the most recent figure standing at $283008.0 for Q4 2025.
- Quarterly Shares Issued fell 80.38% year-over-year to $283008.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $283008.0 (down 80.38% YoY) and the FY2025 annual result came in at $283008.0, down 80.38% from the prior year.
- Shares Issued was $283008.0 for Q4 2025 at Oramed Pharmaceuticals, down from $1.4 million in the prior quarter.
- Across five years, Shares Issued topped out at $2.0 million in Q4 2022 and bottomed at $86500.0 in Q3 2023.
- A 5-year average of $1.1 million and a median of $1.1 million in 2024 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2024 — Shares Issued soared 1128.32% — and 2025, when it plunged 80.38%.
- Oramed Pharmaceuticals' Shares Issued stood at $859447.0 in 2021, then surged by 137.56% to $2.0 million in 2022, then slipped by 6.47% to $1.9 million in 2023, then declined by 24.48% to $1.4 million in 2024, then plunged by 80.38% to $283008.0 in 2025.
- Business Quant data shows ORMP's Shares Issued at $283008.0 in Q4 2025, $1.4 million in Q4 2024, and $1.1 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 19.44 Mn |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 283,008.00 |
| Dec 31, 2025 | 283,008.00 |
| Dec 31, 2024 | 1.44 Mn |
| Dec 31, 2024 | 1.44 Mn |
| Sep 30, 2024 | 1.06 Mn |
| Sep 30, 2024 | 1.06 Mn |
| Dec 31, 2023 | 1.91 Mn |
| Dec 31, 2023 | 1.91 Mn |
| Sep 30, 2023 | 86,500.00 |
| Sep 30, 2023 | 86,500.00 |
| Dec 31, 2022 | 2.04 Mn |
| Dec 31, 2022 | 2.04 Mn |
| Aug 31, 2021 | 859,447.00 |
| Aug 31, 2021 | 859,447.00 |
| Aug 31, 2020 | 103,152.00 |
| Aug 31, 2020 | 103,152.00 |
| Aug 31, 2019 | 47,152.00 |
| Aug 31, 2019 | 47,152.00 |
| Aug 31, 2018 | 55,486.00 |
| Aug 31, 2018 | 55,486.00 |